Neuronomics AG Secured: DeFi Technologies Boosts Stake to 52.5%
Deal News | Mar 07, 2025 | PR Newswire Cision DeFi Technologies Inc.
DeFi Technologies Inc., a Canadian fintech firm, has increased its stake in Neuronomics AG, a Swiss asset management company, to 52.5%. Neuronomics, specializing in artificial intelligence (AI) and quantitative trading strategies, is now majority-owned by DeFi Technologies. This strategic acquisition aligns with DeFi's plan to expand its AI capabilities and diversify income streams, bolstering their existing DeFi Alpha trading desk. Neuronomics employs advanced, model-driven quantitative strategies to deliver superior risk-adjusted performance, often surpassing industry benchmarks. The acquisition emphasizes technological innovation and positions DeFi Technologies for sustained growth in asset management and the broader cryptocurrency market. Neuronomics leverages AI models to enhance forecasting accuracy and optimize asset allocation, and employs computational neuroscience to identify market inefficiencies influenced by cognitive biases. No broker fees were involved, and the transaction awaits approval from the Cboe Canada Exchange.
Sectors
- Financial Technology (FinTech)
- Artificial Intelligence
- Asset Management
- Cryptocurrency
Geography
- Canada – DeFi Technologies Inc. is a Canadian-based Financial Technology company.
- Switzerland – Neuronomics AG is a Swiss asset management company, indicating Switzerland's involvement in the transaction.
Industry
- Financial Technology (FinTech) – DeFi Technologies operates within the financial technology sector, focusing on leveraging technology to enhance financial services.
- Artificial Intelligence – Neuronomics AG specializes in AI-driven strategies, highlighting its role within the artificial intelligence industry.
- Asset Management – The acquisition involves an asset management company, emphasizing the industry's focus on managing clients' assets to achieve specific investment goals.
- Cryptocurrency – Both Neuronomics' and DeFi Technologies' strategies are deeply embedded in the cryptocurrency market, focusing on digital asset management.
Financials
- 52.5% – Proportion of stake acquired by DeFi Technologies in Neuronomics AG.
- 186,304 shares – Number of common shares issued by DeFi Technologies as part of the acquisition payment.
- 80% – Annual return from a recently developed AI-driven quantitative strategy.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| DeFi Technologies Inc. | Bidding Company | Company | A fintech company pioneering the integration of traditional capital markets with decentralized finance. |
| Neuronomics AG | Target Company | Company | A Swiss asset management firm specializing in AI and quantitative trading strategies. |
| Dr. Lorric Ziegler | Partner | Person | Expert in AI and computational neuroscience, responsible for optimizing Neuronomics' processes. |
| Dr. Michael Kometer | Co-Founder and Board Member | Person | A key figure in Neuronomics, specializing in algorithmic trading and neuroscience. |
| Patrick Schuppli | Partner | Person | Manages operational affairs at Neuronomics with expertise in commodity trading and blockchain. |
| Gilles Ramstein | AI Scientist | Person | Specialist in machine learning and data science at Neuronomics, enhancing prediction models. |